Literature DB >> 8748673

Antidepressant-like effects of SR 57227A, a 5-HT3 receptor agonist, in rodents.

M Poncelet1, A Perio, J Simiand, G Gout, P Soubrie, G Le Fur.   

Abstract

We have investigated the effect of SR 57227A, a selective 5-HT3 receptor agonist which crosses the blood brain barrier, on three rodent models in which antidepressants are active. In the forced swimming test, SR 57227A dose-dependently reduced the duration of immobility in mice and rats after i.p. administration. (ED50 = 14.2 mg/kg i.p. in mice, and 7.6 mg/kg i.p. in rats.) The compound was also active in both species after oral administration. In a time-course study in mice, SR 57227A (20 mg/kg p.o.) produced a significant effect lasting 6 h. SR 57227A (1 and 3 mg/kg i.p.) reduced the elevation of the escape failures in the learned helplessness model in rats by 50-60% on the last two days of the avoidance task, and reduced isolation-induced aggressivity in mice by 50 to 85%, an effect which was antagonised by zacopride (1 mg/kg i.p.). These results suggest that the stimulation of 5-HT3 receptors can produce antidepressant-like effects in behavioral tests in rodents.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8748673     DOI: 10.1007/bf01276504

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  19 in total

1.  Acute versus repeated administration of desipramine in rats and mice: relationships between brain concentrations and reduction of immobility in the swimming test.

Authors:  M Poncelet; G Gaudel; S Danti; P Soubrié; P Simon
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding.

Authors:  G J Kilpatrick; B J Jones; M B Tyers
Journal:  Nature       Date:  1987 Dec 24-31       Impact factor: 49.962

3.  Depression: a new animal model sensitive to antidepressant treatments.

Authors:  R D Porsolt; M Le Pichon; M Jalfre
Journal:  Nature       Date:  1977-04-21       Impact factor: 49.962

4.  Antiemetic properties of the 5HT3-receptor antagonist, GR38032F.

Authors:  R Stables; P L Andrews; H E Bailey; B Costall; S J Gunning; J Hawthorn; R J Naylor; M B Tyers
Journal:  Cancer Treat Rev       Date:  1987-12       Impact factor: 12.111

5.  Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study.

Authors:  A Adell; F Artigas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-03       Impact factor: 3.000

6.  Antidepressant profile in rodents of SR 58611A, a new selective agonist for atypical beta-adrenoceptors.

Authors:  J Simiand; P E Keane; J Guitard; X Langlois; N Gonalons; P Martin; A Bianchetti; G Le Fur; P Soubrié
Journal:  Eur J Pharmacol       Date:  1992-08-25       Impact factor: 4.432

7.  Reversal of helpless behavior by serotonin uptake blockers in rats.

Authors:  P Martin; P Soubrié; A J Puech
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

8.  Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study.

Authors:  N Bel; F Artigas
Journal:  Eur J Pharmacol       Date:  1992-12-08       Impact factor: 4.432

9.  Facilitation of 5-hydroxytryptamine3 receptor desensitization by fluoxetine.

Authors:  P Fan
Journal:  Neuroscience       Date:  1994-09       Impact factor: 3.590

10.  Serotonergic anxiolytics and treatment of depression.

Authors:  D S Robinson; D R Alms; R C Shrotriya; M Messina; P Wickramaratne
Journal:  Psychopathology       Date:  1989       Impact factor: 1.944

View more
  7 in total

Review 1.  The non-antiemetic uses of serotonin 5-HT3 receptor antagonists. Clinical pharmacology and therapeutic applications.

Authors:  A J Greenshaw; P H Silverstone
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

2.  The 5-HT3 receptor is essential for exercise-induced hippocampal neurogenesis and antidepressant effects.

Authors:  M Kondo; Y Nakamura; Y Ishida; S Shimada
Journal:  Mol Psychiatry       Date:  2014-11-18       Impact factor: 15.992

3.  A novel 5HT3 receptor-IGF1 mechanism distinct from SSRI-induced antidepressant effects.

Authors:  M Kondo; Y Koyama; Y Nakamura; S Shimada
Journal:  Mol Psychiatry       Date:  2017-04-25       Impact factor: 15.992

Review 4.  The role of the serotonergic system at the interface of aggression and suicide.

Authors:  M Bortolato; N Pivac; D Muck Seler; M Nikolac Perkovic; M Pessia; G Di Giovanni
Journal:  Neuroscience       Date:  2013-01-16       Impact factor: 3.590

5.  Prenatal Cocaine Disrupts Serotonin Signaling-Dependent Behaviors: Implications for Sex Differences, Early Stress and Prenatal SSRI Exposure.

Authors:  Sarah K Williams; Jean M Lauder; Josephine M Johns
Journal:  Curr Neuropharmacol       Date:  2011-09       Impact factor: 7.363

6.  Anxiolytic-like effects observed in rats exposed to the elevated zero-maze following treatment with 5-HT2/5-HT3/5-HT4 ligands.

Authors:  Rob Bell; Aaron A Duke; Paula E Gilmore; Deaglan Page; Laurent Bègue
Journal:  Sci Rep       Date:  2014-01-24       Impact factor: 4.379

7.  Individual differences in the sensitivity to serotonergic drugs: a pharmacobehavioural approach using rats selected on the basis of their response to novelty.

Authors:  Michel M M Verheij; Jesse V Veenvliet; Tom Groot Kormelink; Maaike Steenhof; Alexander R Cools
Journal:  Psychopharmacology (Berl)       Date:  2009-05-12       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.